- The 30-share BSE index was trading 309 points higher, and the broader NSE Nifty was trading 0.65% higher on Monday at 9:40 am.
- Here’s a list of the top losers and gainers in the Nifty pack.
- These are the top stocks that are buzzing in trade today.
- Check out the latest news and updates on Business Insider.
The 30-share BSE index was trading 309 points higher, and the broader NSE Nifty was trading 0.65% higher on Monday at 9:40 am.
Here’s a list of the top losers and gainers in the Nifty pack.
These are the top stocks in news today.
Ujjivan Small Finance Bank leaps over 10%
The shares of Ujjivan Small Finance Bank gained over 10% after the central bank’s Internal Working Group (IWG) has proposed 12 changes to ownership guidelines and corporate structure for Indian private sector banks. The panel recommends that banks currently under NOHFC (non-operative financial holding company) structure may be allowed to exit from such parameters.
Reliance Industries and Future Retail gain after CCI approval
The shares of Mukesh Ambani-owned Reliance Industries gained over 2% after The Competition Commission has approved Reliance's proposed acquisition of retail, wholesale, logistics and warehousing businesses of Future Group. The ₹24,713 crore deal will boost Reliance Industries' fast-growing retail business.
The shares of Kishore Biyani-led Future Retail were also locked in a 10% upper circuit during the morning trade.
Pfizer shares gain over a percent
The shares of COVID vaccine manufacturer Pfizer gained over a percent after news reports hinted that the UK could give regulatory approval to Pfizer-BioNTech’s COVID-19 vaccine this week, even before the United States authorises it.
CG Power locked in 5% upper circuit
The shares of CG Power were locked in a 5% upper circuit after lenders agreed to a one-time loan restructuring to pave way for the Chennai-based Murugappa Group taking over the scam-hit equipment maker.
CG Power’s total debt stands at ₹2,161 crore, of which a consortium of 14 banks have taken a haircut of ₹1,100 crore and restructured the remaining.
SEE ALSO: Amazon Pharmacy is going to be the first big test of public trust in Prime and will expose the company to more scrutiny
Moderna Covid-19 vaccine to cost govts $25-$37 per dose: CEO